| |
Moreover, technological advancements such as the advent of minimally invasive surgery have altered the landscape for treatment. Medical device industries expect to continue to drive technological advancements as companies are investing heavily in research and development by devoting 7.9 percent of sales on such expenditures.
New analysis from Frost & Sullivan (financialservices.frost.com), U.S. Medical Devices Industry: Investment Analysis, reveals that the industry generated revenues of $75.6 billion in the year 2007 and estimates this to grow at a compound annual growth rate (CAGR) of 9.0 percent for the period 2006-2013.
If you are interested in a virtual brochure, which provides manufacturers, end users, and other industry participants with an overview of the investment analysis and growth opportunities in the U.S. Medical Devices Industry, then send an email to Stacie Kopecki, Corporate Communications, at skopecki_pr[.]frost.com, with your full name, company name, title, telephone number, company email address, company website, city, state, and country. Upon receipt of the above information, an overview will be sent to you by mail.
A positive indicator considered for the demand of medical devices is the aging population Industry sources reveal that 12.4 percent of the total U.S. population (36.7 million people) was above the age of 65 in 2005. This expects to further increase to 20.7 percent of the total U.S. population (86.7 million people) by 2050.
"Neurology, cosmetics and aesthetics, and orthopedic devices are the fastest growing segments in the U.S. medical devices industry," notes Frost & Sullivan Financial Analyst Sheetal Rajani. "A high unmet clinical need, the desire to maintain a healthy and youthful appearance, and the active lifestyle demands from an aging population are driving growth in the neurology, cosmetics & aesthetics, and orthopedics segments, respectively."
The neurostimulation devices segment, in particular, holds tremendous investment potential for venture capital investors. There is a huge unmet clinical need for the treatment of chronic pain and nervous system disorders such as epilepsy, depression, and Parkinson's disease. While there are no cures for these conditions, neurostimulation offers relief by blocking pain signals from traveling to the brain. A minimally invasive surgical approach, fewer side effects, and cost effectiveness are some of the advantages offered by neurostimulation devices over other forms of therapy.
"However, medical device recalls and an increase in device-related deaths have shaken the confidence of patients and compromised the growth in this industry," says Rajani. "There has been a spike in the reports of device-associated injuries, deaths, and malfunctions to 325,742, thereby representing an increase of 77.0 percent over the year 2005."
Overall, there exists significant investment potential for venture capitalists in companies that are developing minimally invasive surgical approaches and/or developing new clinical applications for the treatment of unmet clinical needs. The segments associated with the highest growth potential in the U.S. medical devices industry include neurology, cosmetics and aesthetics, and orthopedics.
U.S. Medical Devices Industry: Investment Analysis is part of the Financial Benchmarking in the Medical Device Industry program, which also includes research services in the following markets: World Medical Devices Industry: Investment Analysis, North American Cardiovascular Devices Market: Investment Analysis, European Cardiology Devices Market: Investment Analysis, North American Healthcare Equipment Financing and Leasing Market - Investment Analysis, North American Homecare Market - Investment Analysis, World Orthopedic Devices Market - Investment Analysis, and U.S. Neurological Devices Market - Investment Analysis. All research services included in subscriptions provide detailed market opportunities and industry trends that have been evaluated following extensive interviews with market participants. Interviews with the press are available.
Frost & Sullivan's Business and Financial Services group serves clients around the world in all aspects of financial analysis, market research and monitoring, due diligence, idea generation, opportunity analysis, investment valuation, and other proprietary research.
Frost & Sullivan, the Growth Partnership Company, partners with clients to accelerate their growth. The company's TEAM Research, Growth Consulting and Growth Team Membership empower clients to create a growth-focused culture that generates, evaluates and implements effective growth strategies. Frost & Sullivan employs over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 30 offices on six continents.
U.S. Medical Devices Industry: Investment Analysis / N220
|
stacie.kopecki[.]frost.com 
